The low expression of SLC22A6, SLC22A13, SLC25A4, SLC34A1, and SLC44A4 can also be used as a molecular marker for identifying high-risk subgroups of ccRCC patients. The gene discussed is SLC22A13; the disease is nonpapillary renal cell carcinoma.